RxDoctor Payments Data

Leann Haddock

Obstetrics & Gynecology · Dallas, TXNPI 1811057359

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,113 of the $4,007 with a category attached, or 77.7%. 41 manufacturers reported payments, led by Galderma Laboratories, L.p. at 32.1% of the total. Reporting peaked in 2020 at $1,014 and has fallen 81.3% since, to $189 in 2025.

$4,007in general payments, 2019–2025

Across 159 payments — averaging $25.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$1K
  • AbbVie$571
  • Merz North America, Inc.$388
  • Pfizer$239
  • Mimedx Group, Inc.$200
  • Therapeuticsmd, Inc.$181
  • plus $1K from 35 others

What the payments were for

  • Consulting fees$2005%
  • Speaking & faculty fees$60015%
  • Food & beverage$3,11378%
  • Education$942%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,007 in reported general payments places this provider in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas →

Other obstetrics & gynecology in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →